Incyte (INCY) Cash from Financing Activities (2010 - 2026)

Incyte (INCY) reported Cash from Financing Activities of $84.8 million for Q1 2026, up 769.15% on a YoY basis from $9.8 million in Q1 2025, and down 38.42% quarter-over-quarter from $137.7 million in Q4 2025.

Incyte (INCY) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Incyte has reported Cash from Financing Activities for 17 years, with the latest figure at $84.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 769.15% year-over-year to $84.8 million; the trailing twelve-month figure through Mar 2026 stood at $198.5 million (up 109.82% YoY), and the FY2025 full-year result was $101.0 million, up 105.0% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $84.8 million, down from $137.7 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $137.7 million in Q4 2025, with the low at -$2.0 billion in Q2 2024.
  • Historically, Cash from Financing Activities has averaged -$109.2 million across 5 years, with a median of -$2.5 million in 2022.
  • The largest YoY upside for Cash from Financing Activities was 5794.22% in 2024 against a maximum downside of 15620.49% in 2024.
  • Incyte's Cash from Financing Activities stood at -$2.5 million in 2022, then soared by 113.95% to $346000.0 in 2023, then soared by 5794.22% to $20.4 million in 2024, then soared by 575.39% to $137.7 million in 2025, then sank by 38.42% to $84.8 million in 2026.
  • The last three Cash from Financing Activities figures came in at $84.8 million (Q1 2026), $137.7 million (Q4 2025), and -$12.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 84.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 84.82 Mn
Mar 31, 2026 84.82 Mn
Dec 31, 2025 137.74 Mn
Dec 31, 2025 137.74 Mn
Sep 30, 2025 -12.78 Mn
Sep 30, 2025 -12.78 Mn
Jun 30, 2025 -11.25 Mn
Jun 30, 2025 -11.25 Mn
Mar 31, 2025 -12.68 Mn
Mar 31, 2025 -12.68 Mn
Dec 31, 2024 20.39 Mn
Dec 31, 2024 20.39 Mn
Sep 30, 2024 -32.35 Mn
Sep 30, 2024 -32.35 Mn
Jun 30, 2024 -2.00 Bn
Jun 30, 2024 -2.00 Bn
Mar 31, 2024 -12.41 Mn
Mar 31, 2024 -12.41 Mn
Dec 31, 2023 346,000.00
Dec 31, 2023 346,000.00